Literature DB >> 27591029

Association of GA/HbA1c ratio and cognitive impairment in subjects with type 2 diabetes mellitus.

Tomoe Kinoshita1, Masashi Shimoda1, Junpei Sanada1, Yoshiro Fushimi1, Yurie Hirata1, Shintaro Irie1, Akihito Tanabe1, Atsushi Obata1, Tomohiko Kimura1, Hidenori Hirukawa1, Kenji Kohara1, Fuminori Tatsumi1, Shinji Kamei1, Shuhei Nakanishi1, Tomoatsu Mune1, Kohei Kaku1, Hideaki Kaneto2.   

Abstract

AIMS: The aim of this study was to search for factors influencing cognitive impairment and to clarify the association between the fluctuation of blood glucose levels and cognitive impairment in elderly Japanese subjects with type 2 diabetes.
METHODS: We recruited 88 relatively elderly subjects (≥65years old) with type 2 diabetes who were hospitalized in Kawasaki Medical School from January 2014 to December 2015. We evaluated the fluctuation of blood glucose levels with glycoalbumin (GA)/hemoglobin A1c (HbA1c) ratio, and estimated cognitive impairment with Hasegawa dementia scale-revised (HDS-R) score and mini mental state examination (MMSE) score.
RESULTS: Multivariate analyses showed that GA/HbA1c ratio and urinary albumin excretion, but not hypoglycemia, were independent determinant factors for cognitive impairment in elderly Japanese subjects with type 2 diabetes.
CONCLUSIONS: The fluctuation of blood glucose levels per se is closely associated with cognitive impairment in elderly subjects with type 2 diabetes even when hypoglycemia is not accompanied. Since it is very easy to calculate GA/HbA1c ratio, we should check this ratio so that we can reduce the fluctuation of blood glucose levels especially in elderly subjects with type 2 diabetes.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive impairment; GA/HbA1c ratio; Hasegawa dementia scale-revised; Hypoglycemia; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2016        PMID: 27591029     DOI: 10.1016/j.jdiacomp.2016.08.008

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  6 in total

1.  Glycated Peptide Levels Are Associated With Cognitive Decline Among Nondiabetic Older Women.

Authors:  Siena Duarte; Tina Hoang; Susan K Ewing; Peggy M Cawthon; Steve Cummings; Katie L Stone; Jane A Cauley; Douglas C Bauer; Teresa A Hillier; Kristine Yaffe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-02-15       Impact factor: 6.053

2.  Cognitive Impairment and Related Factors Among Middle-Aged and Elderly Patients with Type 2 Diabetes from a Bio-Psycho-Social Perspective.

Authors:  Weiran Xu; Xiling Hu; Xing Zhang; Cong Ling; Chaofan Wang; Lingling Gao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-10-28       Impact factor: 3.168

3.  Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies.

Authors:  Xue Zhao; Qing Han; You Lv; Lin Sun; Xiaokun Gang; Guixia Wang
Journal:  Oncotarget       Date:  2017-12-14

4.  White Matter Hyperintensity in Elderly Patients with Diabetes Mellitus Is Associated with Cognitive Impairment, Functional Disability, and a High Glycoalbumin/Glycohemoglobin Ratio.

Authors:  Yoshiaki Tamura; Yoshiyuki Kimbara; Takuya Yamaoka; Ken Sato; Yuki Tsuboi; Remi Kodera; Yuko Chiba; Seijiro Mori; Yoshinori Fujiwara; Aya M Tokumaru; Hideki Ito; Takashi Sakurai; Atsushi Araki
Journal:  Front Aging Neurosci       Date:  2017-07-06       Impact factor: 5.750

Review 5.  Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications.

Authors:  Zhen-Ye Zhang; Ling-Feng Miao; Ling-Ling Qian; Ning Wang; Miao-Miao Qi; Yu-Min Zhang; Shi-Peng Dang; Ying Wu; Ru-Xing Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

6.  Factors associated with social isolation and being homebound among older patients with diabetes: a cross-sectional study.

Authors:  Satoshi Ida; Ryutaro Kaneko; Kanako Imataka; Kaoru Okubo; Yoshitaka Shirakura; Kentaro Azuma; Ryoko Fujiwara; Hiroka Takahashi; Kazuya Murata
Journal:  BMJ Open       Date:  2020-11-05       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.